ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EPOC Epocrates, Inc. (MM)

11.73
0.00 (0.00%)
26 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Epocrates, Inc. (MM) NASDAQ:EPOC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.73 0 01:00:00

Epocrates Inc. (EPOC) is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary Duties

30/01/2013 4:43pm

Business Wire


Epocrates, Inc. (MM) (NASDAQ:EPOC)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Epocrates, Inc. (MM) Charts.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Epocrates, Inc. (“Epocrates” or the “Company”) (NASDAQ: EPOC) for potential breaches of fiduciary duties in connection with their duty to disclose material information in the Preliminary Proxy (“Proxy”) filed with the Securities and Exchange Commission on January 25, 2013 in relation to the sale of the Company to athenahealth Inc. (NASDAQ: ATHN) in an all-cash deal valued at approximately $293 million. Furthermore, the price per share agreed to in the proposed transaction is also under investigation since Epocrates’ stockholders will receive only $11.75 in cash for each share of Epocrates common stock they own, while according to Yahoo! Finance, at least one financial analyst has set a price target of $13 for Epocrates.

Request more information now by clicking here: www.faruqilaw.com/EPOC. There is no cost or obligation to you.

The investigation focuses on whether Epocrates’ Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to disclose all material information in the Proxy and to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, and on whether and by how much this proposed transaction undervalues the Company to the detriment of Epocrates’ shareholders.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in Epocrates and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/EPOC or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

1 Year Epocrates, Inc. (MM) Chart

1 Year Epocrates, Inc. (MM) Chart

1 Month Epocrates, Inc. (MM) Chart

1 Month Epocrates, Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock